Critical appraisal of the use of regorafenib in the management of colorectal cancer

The lack of valid clinical management options for patients affected by metastatic colorectal cancer, which has progressed after all approved standard treatments, has lead to research into new active molecules. Regorafenib is an oral small-molecule multi kinase inhibitor, binding to several intracell...

Descripción completa

Detalles Bibliográficos
Autores principales: Festino, Lucia, Fabozzi, Alessio, Manzo, Anna, Gambardella, Valentina, Martinelli, Erika, Troiani, Teresa, De Vita, Ferdinando, Orditura, Michele, Ciardiello, Fortunato, Morgillo, Floriana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3628528/
https://www.ncbi.nlm.nih.gov/pubmed/23610528
http://dx.doi.org/10.2147/CMAR.S34281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3628528/
https://www.ncbi.nlm.nih.gov/pubmed/23610528
http://dx.doi.org/10.2147/CMAR.S34281

Ejemplares similares